This is in accord with other studies showing circulating kallistatin to be elevated in patients with diabetic vascular complications compared to control and subjects with diabetes with no vascular complications (Jenkins et al., 2010; McBride et al., 2014; El‐Asrar et al., 2015). This evidence concerns the gene SERPINA4 and diabetes mellitus.